Severe conjugated hyperbilirubinaemia and neonatal haemolysis

C Allgood1, S Bolisetty

  • 1Department of Newborn Care, Royal Hospital for Women, Sydney, NSW, Australia.

Insights

Two neonates with Rh anti-C isoimmunisation and hereditary pyropoikilocytosis experienced severe, early-onset conjugated hyperbilirubinaemia. This highlights the critical need for prompt diagnosis and management of neonatal jaundice.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Gastroenterology

Background:

  • Neonatal jaundice is common, but severe conjugated hyperbilirubinaemia requires thorough investigation.
  • Rh isoimmunisation and hereditary pyropoikilocytosis are known causes of haemolytic disease in newborns.

Observation:

  • Two neonates presented with severe, early-onset conjugated hyperbilirubinaemia.
  • One neonate had Rh anti-C isoimmunisation; the other had hereditary pyropoikilocytosis.

Findings:

  • Both cases demonstrated a link between specific haemolytic conditions and severe conjugated hyperbilirubinaemia.
  • Early onset and severity of jaundice were key clinical features.

Implications:

  • These findings underscore the importance of considering haemolytic disorders in the differential diagnosis of severe neonatal conjugated hyperbilirubinaemia.
  • Prompt identification and management of underlying aetiologies are crucial for preventing long-term complications.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.